Market Overview:
The global pharmaceutical contract research and manufacturing (CRAM) market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the CRAM market can be attributed to the increasing demand for outsourcing of pharmaceutical and biotechnology services by small and medium-sized enterprises (SMEs). In addition, the growing focus on cost containment is also driving the growth of this market. The CRO segment is expected to account for the largest share of the global CRAM market in 2018. This can be attributed to the increasing demand for contract research services by pharmaceutical and biotechnology companies. The CMO segment is projected to grow at a higher rate than other segments during the forecast period.
 Industry Outlook.svg)
Product Definition:
Pharmaceutical Contract Research and Manufacturing (CRAM) is the provision of outsourced services by a third party to support the development and commercialization of new pharmaceutical products. The importance of Pharmaceutical Contract Research and Manufacturing (CRAM) is that it can help speed up the drug development process, while also reducing costs.
Contract Research Organizations (CRO):
CROs are organizations that provide services to Pharmaceutical and Biotechnological Companies for conducting research activities. They help the client to reduce overall cost of research along with providing high quality of service. The main objective of CROs is to increase the efficiency and effectiveness by reducing time-to-market, enhancing manufacturing process, improving safety & efficacy profiles as well as meet regulatory requirements.
The global contract research organization market was valued at USD 27 billion in 2015.
Contract Manufacturing Organizations (CMO):
CMOs are organizations that manufacture products for other pharmaceutical companies. They are involved in the development of generic drugs, biosimilars, and innovator drugs. CMOs also provide services such as fill-finish manufacturing and final product packaging.
Application Insights:
The other application segment includes the manufacturing of active pharmaceutical ingredients (API), biologics, vaccines and other drugs. The contract research organizations are majorly used for drug discovery & development and clinical trials. In 2017, the pharmaceutical segment dominated the overall market in terms of revenue share at over 60%. This is attributed to factors such as growing R&D activities by various companies for discovering new medicines with better therapeutic effects.
Pharmaceutical companies usually outsource their API production to CROs that have extensive experience in producing high quality products on time according to specifications. Similarly, biopharmaceutical companies outsource their clinical trial activities to CROs that have extensive experience in conducting efficient clinical trials and complying with regulatory requirements associated with these trials.
Regional Analysis:
Asia Pacific CRAM market is anticipated to grow at a lucrative rate over the forecast period. The growth of this region can be attributed to increasing R&D activities and rising healthcare spending in emerging economies such as China, India, and South Korea. In addition, growing awareness regarding advanced technologies for drug development is expected to drive regional market growth during the forecast period.
The Asia Pacific CRAM market was valued at USD X billion in 2017 owing to factors such as increasing outsourcing of clinical trials from North America and Europe coupled with growing demand for generic drugs in countries like China and Japan. Furthermore, an increase in government funding for pharmaceutical research along with favorable regulations aimed at promoting domestic manufacturing has fueled the Asia Pacific CRAM industry growth over the past few years.
Growth Factors:
- Increasing demand for generic drugs and biologics: The global pharmaceutical market is expected to grow at a CAGR of 6.5% from 2016 to 2020, reaching a value of ,155.8 billion by 2020. This growth is primarily attributed to the increasing demand for generic drugs and biologics due to their low cost and high efficacy as compared to branded drugs.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and heart disease is increasing rapidly across the globe due to changing lifestyles and aging populations. This is leading to an increase in the demand for effective treatment therapies, which in turn is driving the growth of the pharmaceutical market.
- Growing investment in R&D by pharma companies: Pharmaceutical companies are investing heavily in R&D activities in order to develop new drug molecules that can be used for treating various chronic diseases. This is resulting in an increase in the number of drug approvals by regulatory authorities, which is driving the growth of the CRAM market worldwide
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Contract Research and Manufacturing (CRAM) Market Research Report
By Type
Contract Research Organizations (CRO), Contract Manufacturing Organizations (CMO)
By Application
Pharmaceutical, Biotechnology, Other
By Companies
Boehringer Ingelheim International GmbH, Catalent, Inc, IQVIA, Lonza, Thermo Fisher Scientific Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Report Segments:
The global Pharmaceutical Contract Research and Manufacturing (CRAM) market is segmented on the basis of:
Types
Contract Research Organizations (CRO), Contract Manufacturing Organizations (CMO)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical, Biotechnology, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim International GmbH
- Catalent, Inc
- IQVIA
- Lonza
- Thermo Fisher Scientific Inc.
 Market Overview.svg)
Highlights of The Pharmaceutical Contract Research and Manufacturing (CRAM) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Contract Research Organizations (CRO)
- Contract Manufacturing Organizations (CMO)
- By Application:
- Pharmaceutical
- Biotechnology
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Contract Research and Manufacturing (CRAM) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical contract research and manufacturing (CRAM) is a process that involves contracting with third-party manufacturers to produce pharmaceutical products. CRAM services can include the development of drug formulations, the production of clinical trials materials, and the manufacture of finished products.
Some of the major players in the pharmaceutical contract research and manufacturing (cram) market are Boehringer Ingelheim International GmbH, Catalent, Inc, IQVIA, Lonza, Thermo Fisher Scientific Inc..
The pharmaceutical contract research and manufacturing (cram) market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Contract Research and Manufacturing (CRAM) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Contract Research and Manufacturing (CRAM) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Type
5.2.1 Contract Research Organizations (CRO)
5.2.2 Contract Manufacturing Organizations (CMO)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Applications
6.2.1 Pharmaceutical
6.2.2 Biotechnology
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical Contract Research and Manufacturing (CRAM) Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Type
9.6.1 Contract Research Organizations (CRO)
9.6.2 Contract Manufacturing Organizations (CMO)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Applications
9.10.1 Pharmaceutical
9.10.2 Biotechnology
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical Contract Research and Manufacturing (CRAM) Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Type
10.6.1 Contract Research Organizations (CRO)
10.6.2 Contract Manufacturing Organizations (CMO)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Applications
10.10.1 Pharmaceutical
10.10.2 Biotechnology
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical Contract Research and Manufacturing (CRAM) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Type
11.6.1 Contract Research Organizations (CRO)
11.6.2 Contract Manufacturing Organizations (CMO)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Applications
11.10.1 Pharmaceutical
11.10.2 Biotechnology
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical Contract Research and Manufacturing (CRAM) Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Type
12.6.1 Contract Research Organizations (CRO)
12.6.2 Contract Manufacturing Organizations (CMO)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Applications
12.10.1 Pharmaceutical
12.10.2 Biotechnology
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical Contract Research and Manufacturing (CRAM) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Type
13.6.1 Contract Research Organizations (CRO)
13.6.2 Contract Manufacturing Organizations (CMO)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Forecast by Applications
13.10.1 Pharmaceutical
13.10.2 Biotechnology
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Contract Research and Manufacturing (CRAM) Market: Competitive Dashboard
14.2 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer Ingelheim International GmbH
14.3.2 Catalent, Inc
14.3.3 IQVIA
14.3.4 Lonza
14.3.5 Thermo Fisher Scientific Inc.
